Audrey Guttin

Title: Audrey Guttin: Innovator in Ovarian Carcinoma Research

Introduction

Audrey Guttin is a prominent inventor based in Saint-Martin-Le-Vinoux, France. She has made significant contributions to the field of medical research, particularly in the area of ovarian carcinoma. Her work focuses on the identification of biomarkers that can aid in the diagnosis and prognosis of high-grade serous ovarian carcinoma.

Latest Patents

Audrey Guttin holds a patent titled "Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care." This patent relates to the identification of a circulating miRNA biomarker that is suitable for use in diagnosing and prognosticating high-grade serous ovarian carcinoma (HGSOC). Additionally, it includes the development of diagnostic kits for such purposes.

Career Highlights

Throughout her career, Guttin has worked with esteemed institutions such as Université de Caen Normandie and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing the understanding of ovarian cancer and improving therapeutic care options.

Collaborations

Audrey Guttin has collaborated with notable colleagues, including Nicolas Vigneron and Christophe Denoyelle. These partnerships have contributed to her innovative research and the successful development of her patent.

Conclusion

Audrey Guttin is a trailblazer in the field of ovarian carcinoma research, with her innovative patent and collaborations paving the way for advancements in medical diagnostics. Her contributions are vital for improving patient care and outcomes in the fight against cancer.